Biotech startup using organelle engineering to develop novel, high-value traits for agricultural crops.
About
Cytotrait is a biotechnology spinout from the University of Manchester that utilizes its proprietary Mutant Organelle Selection System (MOSS) to precisely edit chloroplast and mitochondrial genomes in plants. This technology enables the development of crops with enhanced yield, resilience, and new food traits, while potentially streamlining regulatory pathways compared to conventional nuclear genome engineering.
Tags
Total Employees
5
Current headcount
Score Breakdown
10Traction
40Team
60Visibility
13Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Cytotrait do?
Cytotrait is a biotechnology spinout from the University of Manchester that utilizes its proprietary Mutant Organelle Selection System (MOSS) to precisely edit chloroplast and mitochondrial genomes in plants. This technology enables the development of crops with enhanced yield, resilience, and new food traits, while potentially streamlining regulatory pathways compared to conventional nuclear genome engineering.
How much funding has Cytotrait raised?
Cytotrait has raised a total of $3M in funding. The most recent round on record is Seed.
Where is Cytotrait headquartered?
Cytotrait is headquartered in United Kingdom.
When was Cytotrait founded?
Cytotrait was founded in 2026.
What industry does Cytotrait operate in?
Cytotrait operates in Agriculture, Biotechnology, Gene Editing, Biotech, Agritech, Deep Tech.
How many employees does Cytotrait have?
Cytotrait has approximately 5 people on record.